Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 2019; Volume 96,Issue 5

Special Section on Computational Analysis of GPCRs

  • Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
    You have access
    Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
    Christopher T. Szlenk, Jeevan B. GC and Senthil Natesan
    Molecular Pharmacology November 2019, 96 (5) 527-541; DOI: https://doi.org/10.1124/mol.118.115113
  • You have access
    A Biased View of μ-Opioid Receptors?
    Alexandra E. Conibear and Eamonn Kelly
    Molecular Pharmacology November 2019, 96 (5) 542-549; DOI: https://doi.org/10.1124/mol.119.115956
  • You have access
    Understanding Peptide Binding in Class A G Protein-Coupled Receptors
    Irina G. Tikhonova, Veronique Gigoux and Daniel Fourmy
    Molecular Pharmacology November 2019, 96 (5) 550-561; DOI: https://doi.org/10.1124/mol.119.115915

Articles

  • Open Access
    The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison
    Ian G. Cowell, Elise M. Ling, Rebecca L. Swan, Matilda L.W. Brooks and Caroline A. Austin
    Molecular Pharmacology November 2019, 96 (5) 562-572; DOI: https://doi.org/10.1124/mol.119.117390
  • You have access
    Arylamine N-Acetyltransferase 1 Regulates Expression of Matrix Metalloproteinase 9 in Breast Cancer Cells: Role of Hypoxia-Inducible Factor 1-α
    Pengcheng Li, Neville J. Butcher and Rodney F. Minchin
    Molecular Pharmacology November 2019, 96 (5) 573-579; DOI: https://doi.org/10.1124/mol.119.117432
  • You have access
    Metal Coordination Is Crucial for Geranylgeranyl Diphosphate Synthase–Bisphosphonate Interactions: A Crystallographic and Computational Analysis
    Michal Lisnyansky, Elon Yariv, Omri Segal, Milit Marom, Anat Loewenstein, Nir Ben-Tal, Moshe Giladi and Yoni Haitin
    Molecular Pharmacology November 2019, 96 (5) 580-588; DOI: https://doi.org/10.1124/mol.119.117499
  • You have access
    Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo
    Zhi-Xing Cao, Yi Wen, Jun-Lin He, Shen-Zhen Huang, Fei Gao, Chuan-Jie Guo, Qing-Qing Liu, Shu-Wen Zheng, Dao-Yin Gong, Yu-Zhi Li, Ruo-Qi Zhang, Jian-Ping Chen and Cheng Peng
    Molecular Pharmacology November 2019, 96 (5) 589-599; DOI: https://doi.org/10.1124/mol.119.116129
  • You have access
    CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis
    Kaoru Kobayashi, Jiro Kuze, Satoshi Abe, Shoko Takehara, Genki Minegishi, Katsuhide Igarashi, Satoshi Kitajima, Jun Kanno, Takushi Yamamoto, Mitsuo Oshimura and Yasuhiro Kazuki
    Molecular Pharmacology November 2019, 96 (5) 600-608; DOI: https://doi.org/10.1124/mol.119.117333
  • Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative
    You have access
    Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative
    Jun-ichi Sawada, Hirosuke Ishii, Kenji Matsuno, Masayuki Sato, Yumiko Suzuki and Akira Asai
    Molecular Pharmacology November 2019, 96 (5) 609-618; DOI: https://doi.org/10.1124/mol.119.116624
  • You have access
    Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist
    Robert B. Laprairie, Kiran Vemuri, Edward L. Stahl, Anisha Korde, Jo-Hao Ho, Travis W. Grim, Tian Hua, Yiran Wu, Raymond C. Stevens, Zhi-Jie Liu, Alexandros Makriyannis and Laura M. Bohn
    Molecular Pharmacology November 2019, 96 (5) 619-628; DOI: https://doi.org/10.1124/mol.119.116483
  • You have access
    A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein
    Tobie D. Lee, Olivia W. Lee, Kyle R. Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G. Tebase, Carleen Klumpp-Thomas, Robert W. Robey, Suresh V. Ambudkar, Min Shen, Michael M. Gottesman and Matthew D. Hall
    Molecular Pharmacology November 2019, 96 (5) 629-640; DOI: https://doi.org/10.1124/mol.119.115964
  • You have access
    Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-Ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance
    Doyoung Kwon, Sung-Mi Kim, Peyton Jacob, Yi Liu and Maria Almira Correia
    Molecular Pharmacology November 2019, 96 (5) 641-654; DOI: https://doi.org/10.1124/mol.119.117069
  • You have access
    The Basis for Strain-Dependent Rat Aldehyde Dehydrogenase 1A7 (ALDH1A7) Gene Expression
    Katerina Touloupi, Jenni Küblbeck, Angeliki Magklara, Ferdinand Molnár, Mika Reinisalo, Maria Konstandi, Paavo Honkakoski and Periklis Pappas
    Molecular Pharmacology November 2019, 96 (5) 655-663; DOI: https://doi.org/10.1124/mol.119.117424
  • You have access
    Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors
    Dmitry S. Lebedev, Elena V. Kryukova, Igor A. Ivanov, Natalia S. Egorova, Nikita D. Timofeev, Ekaterina N. Spirova, Elizaveta Yu. Tufanova, Andrei E. Siniavin, Denis S. Kudryavtsev, Igor E. Kasheverov, Marios Zouridakis, Ramaz Katsarava, Nino Zavradashvili, Ia Iagorshvili, Socrates J. Tzartos and Victor I. Tsetlin
    Molecular Pharmacology November 2019, 96 (5) 664-673; DOI: https://doi.org/10.1124/mol.119.117713

Erratum

  • You have access
    Correction to “Identification of Abundant and Evolutionarily Conserved Opioid Receptor Circular RNAs in the Nervous System Modulated by Morphine”
    Molecular Pharmacology November 2019, 96 (5) 526; DOI: https://doi.org/10.1124/mol.119.113977err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 96 (5)
Molecular Pharmacology
Vol. 96, Issue 5
1 Nov 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Section on Computational Analysis of GPCRs
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics